CareDx, Inc
General ticker "CDNA" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $987.1M (TTM average)
CareDx, Inc does not follow the US Stock Market performance with the rate: -2.7%.
Estimated limits based on current volatility of 3.1%: low 17.99$, high 19.14$
Factors to consider:
- Total employees count: 650 (+1.1%) as of 2024
- US accounted for 74.4% of revenue in the fiscal year ended 2024-12-31
- Top business risk factors: Senior management loss, Labor/talent shortage/retention, Third-party risks, Regulatory and compliance, Economic downturns and volatility
- Price in estimated range
- Earnings for 9 months up through Q3 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [14.89$, 31.91$]
- 2025-12-31 to 2026-12-31 estimated range: [11.21$, 25.09$]
Financial Metrics affecting the CDNA estimates:
- Positive: with PPE of 38.9 at the end of fiscal year the price was neutral
- Positive: 7.86 < Operating profit margin, % of 12.21
- Negative: negative Industry operating cash flow (median)
- Positive: 0.33 < Operating cash flow per share per price, % of 3.43
- Negative: Industry earnings per price (median), % of 0 <= 0
- Positive: Industry inventory ratio change (median), % of -0.79 <= -0.15
- Positive: Return on assets ratio (scaled to [-100,100]) of 9.67 > 6.04
- Positive: Interest expense per share per price, % of 0 <= 0.01
Short-term CDNA quotes
Long-term CDNA plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $321.79MM | $280.32MM | $333.79MM |
| Operating Expenses | $399.02MM | $483.69MM | $293.02MM |
| Operating Income | $-77.23MM | $-203.36MM | $40.77MM |
| Non-Operating Income | $1.00MM | $13.22MM | $12.09MM |
| R&D Expense | $90.39MM | $81.87MM | $72.41MM |
| Income(Loss) | $-76.23MM | $-190.14MM | $52.86MM |
| Taxes | $0.38MM | $0.14MM | $0.31MM |
| Profit(Loss)* | $-76.61MM | $-190.28MM | $52.55MM |
| Stockholders Equity | $430.91MM | $261.33MM | $378.43MM |
| Inventory | $19.23MM | $19.47MM | $19.50MM |
| Assets | $542.99MM | $466.83MM | $491.05MM |
| Operating Cash Flow | $-25.24MM | $-18.39MM | $38.05MM |
| Capital expenditure | $24.33MM | $9.24MM | $6.48MM |
| Investing Cash Flow | $-228.50MM | $40.45MM | $-0.48MM |
| Financing Cash Flow | $-4.54MM | $-29.61MM | $-5.61MM |
| Earnings Per Share** | $-1.44 | $-3.54 | $1.00 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.